Literature DB >> 301852

Quantification of antibodies to the C3d subcomponent of human C3.

H Chaplin, J Freedman, N C Hughes-Jones.   

Abstract

Purified soluble C3d has been employed to measure the concentration of anti-C3d antibodies in immune rabbit sera. Multiple batches of C3d, prepared from C3-C3b substrate by treatment with C3b-inactivator (KAF), after labelling with 125I, retained 80% immunoreactivity, and were stable on storage at -50 degrees and +4 degrees. Concentrations of anti-C3d were determined by Scatchard analysis of equilibrium concentrations of bound and free C3d in a mixture of 125I-labelled C3d and anti-C3d. Separation of bound from free C3d was by G-75 Sephadex filtration. Assuming a 1:1 molar ratio in the antibody-C3d complex, anti-C3d antibody concentrations for four rabbit whole antisera and four IgG preparations fell in the range 288-2433 microgram/ml, with Ko values of 6-2 X 10(8)-2-9 X 10(9) litres/mol. One commercial antiglobulin-serum contained 3-6 microgram anti C3d/ml and had a Ko value of 1-7 X 10(8) litres/mol. Values for anti-C3d concentrations measured independently by an indirect method employing 125I-labelled sheep anti-rabbit IgG averaged 20% lower than those obtained with 125I-labelled C3d. Antibody concentrations were correlated with antiglobulin agglutination titres against C3d-coated red cells; a titre of 1 was given by an anti-C3d concentration of 0-5 microgram/ml.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 301852      PMCID: PMC1445437     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  9 in total

1.  Purification and use of the C3d subunit C3.

Authors:  J A Moore; J M Michael; H Chaplin
Journal:  Transfusion       Date:  1976 May-Jun       Impact factor: 3.157

2.  Clinical usefulness of specific antiglobulin reagents in autoimmune hemolytic anemias.

Authors:  H Chaplin
Journal:  Prog Hematol       Date:  1973

3.  Effect of chemical and enzymatic radioiodination on in vitro human Clq activities.

Authors:  C Heusser; M Boesman; J H Nordin; H Isliker
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

4.  Preparation of red cells coated with C4 and C3 subcomponents and production of anti-C4d and anti-C3d.

Authors:  J Freedman; P L Mollison
Journal:  Vox Sang       Date:  1976-10       Impact factor: 2.144

5.  Autoimmune haemolytic anaemias. 3. Preparation and examination of specific antisera against complement components and products, and their use in serological studies.

Authors:  C P Engelfriet; K W Pondman; G Wolters; D Beckers; G Misset-Groenveld; J J van Loghem
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

6.  The use of purified 125-I-labelled anti-gamma globulin in the determination of the number of D antigen sites on red cells of different phenotypes.

Authors:  E Rochna; N C Hughes-Jones
Journal:  Vox Sang       Date:  1965 Nov-Dec       Impact factor: 2.144

7.  Physico-chemical and antigenic properties of human C3.

Authors:  J L Molenaar; A W Helder; M A Müller; M Goris-Mulder; L S Jonker; M Brouwer; K W Pondman
Journal:  Immunochemistry       Date:  1975-05

8.  Identification of a C4 Subcomponent on C3d-coated erythrocytes.

Authors:  J M Michael; J A Moore; H Chaplin
Journal:  Transfusion       Date:  1976 Sep-Oct       Impact factor: 3.157

9.  Third component of complement (C3): structural properties in relation to functions.

Authors:  V A Bokisch; M P Dierich; H J Mūller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

  9 in total
  2 in total

1.  False-positive antiglobulin tests in healthy subjects and in hospital patients.

Authors:  J Freedman
Journal:  J Clin Pathol       Date:  1979-10       Impact factor: 3.411

2.  Quantitation of C3 subcomponents on red cells coated with complement in vitro.

Authors:  J Freedman; A Massey
Journal:  J Clin Pathol       Date:  1980-10       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.